UBS Starts Walgreens Boosts Alliance (WBA) at Buy
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
UBS initiates coverage on Walgreens Boosts Alliance (NASDAQ: WBA) with a Buy rating and a price target of $94.00.
Analyst Michael Cherny commented, "We are initiating coverage of Walgreens Boots Alliance with a Buy rating and a $94 price target. Walgreens is one of the two largest drug retailers in the US as well as the leading European drug retailer, with a focus on offering a combination of both convenience and differentiated products (including the No7 beauty products from Boots). The company is also in the midst of broadening its channel partnerships through a number of agreements with various different supply chain constituents, all targeted at driving improved productivity of the “box.” Note: UBS is acting as financial advisor to Walgreens in its pending acquisition of Rite Aid."
Shares of Walgreens Boosts Alliance closed at $80.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Seaport Global Securities Starts Canadian Pacific Railway Limited (CP) at Buy
- KLR Group Raises Price Target on SM Energy (SM) to $59; Reiterates Buy
- H.C. Wainwright Downgrades Vertex (VRTX) to Neutral
Create E-mail Alert Related CategoriesAnalyst Comments, New Coverage
Related EntitiesUBS, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!